Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Comparison of stroke- and bleed-related healthcare resource utilization and costs among patients with newly diagnosed non-valvular atrial fibrillation and newly treated with dabigatran, rivaroxaban, or warfarin

PaperCitations, authors & open-access status

Comparison of stroke- and bleed-related healthcare resource utilization and costs among patients with newly diagnosed non-valvular atrial fibrillation and newly treated with dabigatran, rivaroxaban, or warfarin is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 3 citations, 2018 year and closed oa status.

3
Citations
2018
Year
closed
OA Status

Related on ScholarIQ

Amy Sainski‐Nguyen
Author
Expert Review of Pharmacoeconomics & Outcomes Research
Journal
Atrial Fibrillation Management and Outcomes
Topic
Atrial Fibrillation Management and Outcomes
Topic
Intracerebral and Subarachnoid Hemorrhage Research
Topic
Venous Thromboembolism Diagnosis and Management
Topic
470M+ articles · free account